Propanc Biopharma, Inc. (PPCB)
1.07
-0.06
(-5.31%)
USD |
NASDAQ |
Aug 26, 16:00
1.08
+0.01
(+0.93%)
After-Hours: 20:00
Propanc Biopharma Market Cap : 0.9356M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 0.9356M |
| August 25, 2026 | 0.9881M |
| August 24, 2026 | 1.010M |
| August 21, 2026 | 0.9444M |
| August 20, 2026 | 0.9618M |
| August 19, 2026 | 0.9968M |
| August 18, 2026 | 1.014M |
| August 17, 2026 | 1.006M |
| August 14, 2026 | 1.067M |
| August 13, 2026 | 1.067M |
| August 12, 2026 | 1.058M |
| August 11, 2026 | 1.023M |
| August 10, 2026 | 1.006M |
| August 07, 2026 | 1.049M |
| August 06, 2026 | 1.189M |
| August 05, 2026 | 1.032M |
| August 04, 2026 | 0.8919M |
| August 03, 2026 | 0.9181M |
| July 31, 2026 | 0.8831M |
| July 30, 2026 | 0.9094M |
| July 29, 2026 | 0.8657M |
| July 28, 2026 | 1.058M |
| July 27, 2026 | 1.154M |
| July 24, 2026 | 1.198M |
| July 23, 2026 | 1.268M |
| Date | Value |
|---|---|
| July 22, 2026 | 1.259M |
| July 21, 2026 | 1.207M |
| July 20, 2026 | 1.207M |
| July 17, 2026 | 1.303M |
| July 16, 2026 | 1.390M |
| July 15, 2026 | 1.425M |
| July 14, 2026 | 1.425M |
| July 13, 2026 | 1.399M |
| July 10, 2026 | 1.408M |
| July 09, 2026 | 1.556M |
| July 08, 2026 | 1.574M |
| July 07, 2026 | 1.591M |
| July 06, 2026 | 1.644M |
| July 02, 2026 | 1.548M |
| July 01, 2026 | 1.259M |
| June 30, 2026 | 1.312M |
| June 29, 2026 | 1.382M |
| June 26, 2026 | 1.285M |
| June 25, 2026 | 1.320M |
| June 24, 2026 | 1.303M |
| June 23, 2026 | 1.285M |
| June 22, 2026 | 1.294M |
| June 18, 2026 | 1.285M |
| June 17, 2026 | 1.495M |
| June 16, 2026 | 1.688M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 56.00M |
| CSL Ltd. | 59.39B |
| Ceryvyn Therapeutics Ltd. | 3.967M |
| Mesoblast Ltd. | 2.170B |
| Actinogen Medical Ltd. | 101.18M |
Market Cap Related Metrics
| Price to Book Value | 0.0952 |
| Price | 1.07 |
| Earnings Yield | -3.10K% |